Clinical Trial Update: Feasibility of eLi12 [NA]

View source ↗

Summary

A feasibility study of the investigational drug eLi12 for bipolar disorder; the trial is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• eLi12

Snippet

Sponsor: Ole Köhler-Forsberg | Conditions: Bipolar Disorder (BD) | NA | Status: ACTIVE_NOT_RECRUITING